SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Detaylı Bibliyografya
Yazar:	Meem, Manila
Diğer Yazarlar:	Akter, Dr. Raushanara
Materyal Türü:	Tez
Dil:	English
Baskı/Yayın Bilgisi:	Brac University 2023
Konular:	Cancer SHP2 inhibitors Targeted therapy Catalytic inhibitor Allosteric inhibitor. Cancer research.
Online Erişim:	http://hdl.handle.net/10361/18081

Benzer Materyaller

A review on potential of PARP inhibitors in the treatment of prostate cancer
Yazar:: Islam, Saidul
Baskı/Yayın Bilgisi: (2022)

RIPK pathway, as a potential target, for cancer treatment - a review
Yazar:: Jahan, Nusrat
Baskı/Yayın Bilgisi: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Yazar:: Flora, Sanzida Alam
Baskı/Yayın Bilgisi: (2024)

Immunotherapy in the Management of Lung Cancer
Yazar:: Tasnim, Humayra
Baskı/Yayın Bilgisi: (2022)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
Yazar:: Ratu, Tabassum
Baskı/Yayın Bilgisi: (2024)

Recent advances in Cancer treatment targeting autophagy and future aspects
Yazar:: Emon, Kamrul Hasan
Baskı/Yayın Bilgisi: (2022)

Identification of FAP inhibitors using in silico simulation study
Yazar:: Deeba, Maliha Tasnim
Baskı/Yayın Bilgisi: (2018)

A review on the role of Epigenetics in Psychiatry: Etiology, contemporary medicine and future perspectives
Yazar:: Oshin, Sadia Afrin
Baskı/Yayın Bilgisi: (2021)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
Yazar:: Karim, Azrin
Baskı/Yayın Bilgisi: (2024)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
Yazar:: Mirza, Maisa Tasnim
Baskı/Yayın Bilgisi: (2023)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
Yazar:: Khan, Muidul Hasan
Baskı/Yayın Bilgisi: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
Yazar:: Haque, Mushfiqul
Baskı/Yayın Bilgisi: (2019)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
Yazar:: Islam, Nahidul
Baskı/Yayın Bilgisi: (2023)

A review on targeted therapies for lung cancer
Yazar:: Ashraf, Anushey
Baskı/Yayın Bilgisi: (2023)

TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
Yazar:: Afroza, Halima
Baskı/Yayın Bilgisi: (2024)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
Yazar:: Ishrat, Nowshin
Baskı/Yayın Bilgisi: (2024)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
Yazar:: Sorno, Rubina Haque
Baskı/Yayın Bilgisi: (2024)

Effect Of sodium glucose co-transporter 2 inhibitors on weight reduction in overweight and obese population: A review
Yazar:: Mahin, Md. Tamjidur Rahman
Baskı/Yayın Bilgisi: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
Yazar:: Alam, Kazi Tasnuva
Baskı/Yayın Bilgisi: (2022)

Immunotherapeutic approaches to treat cancer: Prospects and challenges
Yazar:: Fred, Namanda Rogers
Baskı/Yayın Bilgisi: (2021)

Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
Yazar:: Khandker, Tahia Anjum
Baskı/Yayın Bilgisi: (2024)

Synthesis and sar o acne medication
Yazar:: Naureen, Tasnia
Baskı/Yayın Bilgisi: (2024)

HPLC method development for the analysis of linagliptin
Yazar:: Mimiya, Ruhani Amrin
Baskı/Yayın Bilgisi: (2020)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
Yazar:: Paul, Pulock
Baskı/Yayın Bilgisi: (2024)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
Yazar:: Kamal, Tasnova
Baskı/Yayın Bilgisi: (2019)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
Yazar:: Tania, Umme
Baskı/Yayın Bilgisi: (2023)

Trend in approval of targeted biologics in the last two decades
Yazar:: Siddika, Khadiza
Baskı/Yayın Bilgisi: (2024)

Breast cancer therapy through Liposomal drug delivery system
Yazar:: Ome, Nusrat Jahan
Baskı/Yayın Bilgisi: (2024)

Epigenetic therapy in cancer
Yazar:: Abid, Md. Shadman Ridwan
Baskı/Yayın Bilgisi: (2021)

A review on triple-negative breast cancer and its potential treatment
Yazar:: Niasa, Jannatul Ferdous
Baskı/Yayın Bilgisi: (2023)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
Yazar:: Razna, Amrin Islam
Baskı/Yayın Bilgisi: (2019)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
Yazar:: Chakraborty, Anuradha
Baskı/Yayın Bilgisi: (2024)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
Yazar:: Nahar, Kamrun
Baskı/Yayın Bilgisi: (2023)

The impact of cell penetrating peptides in prospective cancer therapy: a review
Yazar:: Nashrah, Zannatul
Baskı/Yayın Bilgisi: (2023)

A review on the recent advancements on nanoparticles drug delivery approaches in anti-cancer treatment
Yazar:: Hoque, Syeda Mehren
Baskı/Yayın Bilgisi: (2024)

A review on carbon nanotube: a new era in cancer diagnosis & therapy
Yazar:: Parvez, Safi
Baskı/Yayın Bilgisi: (2023)

Statistics and informatics in molecular cancer research

A comprehensive review on drug repurposing in cancer treatment
Yazar:: Sarkar, Onusree
Baskı/Yayın Bilgisi: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
Yazar:: Hasan, Amit
Baskı/Yayın Bilgisi: (2024)

Art therapy to improve quality of life of cancer patients and their carers in Bangladesh
Yazar:: Dowla, Rumana, ve diğerleri
Baskı/Yayın Bilgisi: (2022)